Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 18, 2023

SELL
$0.22 - $0.4 $7,370 - $13,400
-33,500 Reduced 1.71%
1,930,062 $463,000
Q2 2023

Jul 12, 2023

BUY
$0.35 - $0.6 $1,785 - $3,060
5,100 Added 0.26%
1,963,562 $706,000
Q1 2023

Apr 12, 2023

BUY
$0.55 - $1.17 $169,207 - $359,950
307,650 Added 18.64%
1,958,462 $1.18 Million
Q4 2022

Jan 06, 2023

SELL
$0.6 - $17.32 $3,510 - $101,322
-5,850 Reduced 0.35%
1,650,812 $0
Q3 2022

Oct 14, 2022

BUY
$0.8 - $15.88 $99,863 - $1.98 Million
124,829 Added 8.15%
1,656,662 $1.29 Million
Q2 2022

Jul 07, 2022

BUY
$1.18 - $2.04 $67,024 - $115,872
56,800 Added 3.85%
1,531,833 $2.62 Million
Q1 2022

Apr 27, 2022

BUY
$1.34 - $2.26 $171,998 - $290,086
128,357 Added 9.53%
1,475,033 $2.76 Million
Q4 2021

Jan 25, 2022

BUY
$2.1 - $4.36 $1.34 Million - $2.78 Million
637,165 Added 89.8%
1,346,676 $2.83 Million
Q3 2021

Oct 19, 2021

SELL
$3.9 - $5.67 $27,300 - $39,690
-7,000 Reduced 0.98%
709,511 $2.89 Million
Q2 2021

Aug 02, 2021

BUY
$4.85 - $6.9 $203,753 - $289,875
42,011 Added 6.23%
716,511 $3.84 Million
Q1 2021

Apr 16, 2021

BUY
$6.09 - $12.2 $120,277 - $240,950
19,750 Added 3.02%
674,500 $4.52 Million
Q4 2020

Jan 11, 2021

SELL
$3.56 - $10.21 $488,040 - $1.4 Million
-137,090 Reduced 17.31%
654,750 $5.74 Million
Q3 2020

Oct 22, 2020

BUY
$2.49 - $5.16 $348,948 - $723,122
140,140 Added 21.5%
791,840 $3.17 Million
Q2 2020

Aug 03, 2020

BUY
$1.65 - $3.4 $30,525 - $62,900
18,500 Added 2.92%
651,700 $2.1 Million
Q1 2020

Apr 20, 2020

BUY
$1.52 - $2.66 $962,464 - $1.68 Million
633,200 New
633,200 $1.03 Million

Others Institutions Holding AQB

About AquaBounty Technologies, Inc.


  • Ticker AQB
  • Exchange NASDAQ
  • Sector Consumer Defensive
  • Industry Farm Products
  • Shares Outstandng 71,110,704
  • Market Cap $69.7M
  • Description
  • AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sel...
More about AQB
Track This Portfolio

Track Epiq Partners, LLC Portfolio

Follow Epiq Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Epiq Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Epiq Partners, LLC with notifications on news.